Results 201 to 210 of about 39,459 (248)

[Complex treatment of limited scleroderma with dosed local vacuum therapy].

Vestnik dermatologii i venerologii, 1970
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma

Journal of Clinical Immunology, 2012
Scleroderma (systemic sclerosis, SSc) is a complex autoimmune disease caused by progressive fibrotic replacement of normal tissue architecture, a progressive and ultimately fatal process that currently has no cure. Although dysregulation of microRNAs (miRNAs) is known to be involved in a variety of pathophysiologic processes, the role of miRNAs in SSc ...
Honglin Zhu, Hui Luo, Xiaoxia Zuo
exaly   +3 more sources

Prevalence of Pulmonary Hypertension in Limited and Diffuse Scleroderma

Chest, 1996
To characterize the prevalence of undiagnosed pulmonary hypertension in patients with limited and diffuse scleroderma.Prospective cross-sectional study.University-based outpatient clinic.Thirty-four consecutive patients with limited (n = 29) or diffuse (n = 5) scleroderma but without the clinical diagnosis of pulmonary hypertension.All patients had 12 ...
R W, Battle, M A, Davitt, S M, Cooper, L M, Buckley, E S, Leib, P A, Beglin, M D, Tischler   +6 more
exaly   +3 more sources

Effects of olopatadine in limited scleroderma with peripheral eosinophils

Geriatrics and Gerontology International, 2008
Scleroderma and eosinophilia often occur together, though the pathogenesis is unclear. We investigated the effect of olopatadine hydrochloride in a series of cases of limited scleroderma (LS). Ten patients with LS and positive eosinophil counts (LSE) were enrolled (average age, 85 years; six men and four women).
Motoo, Kikuchi, Toshiaki, Inagaki, Hidekazu, Hanaki, Shinsuke, Harada, Ryuzo, Ueda   +4 more
exaly   +3 more sources

Myasthenia gravis associated with limited scleroderma (CREST syndrome)

Journal of Neurology, 2000
C. Kambara, I. Kinoshita, T. Amenomori, K. Eguchi, T. Yoshimura   +4 more
exaly   +2 more sources

Clinically Significant Interstitial Lung Disease in Limited Scleroderma

Chest, 2008
Aryeh Fischer, Jeffrey J Swigris, David A Lynch   +2 more
exaly   +2 more sources

Improved survival in limited scleroderma-related pulmonary artery hypertension

Internal and Emergency Medicine, 2013
Reportedly, patients with scleroderma-related pulmonary hypertension (SSc-PAH) respond poorly to new vasoactive drugs (NVD). Forty-nine SSc-PAH patients underwent right heart catheterization (RHC) and, according to NVD availability, divided as follows: Group 1 (n = 23, from 1999 to 2004, poor availability), and Group 2 (n = 26, from 2005 to 2010, good ...
Marini C, Formichi B, Bauleo C, Michelassi C, Pancani R, Prediletto R, MINIATI, MASSIMO, Catapano G, Monti S, Mannucci F, Tavoni A, D’Ascanio A, Pastormerlo LE, Giannoni A, Giuntini C.   +14 more
openaire   +5 more sources